Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2007
11/20/2007US7297533 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome
11/20/2007US7297520 Large circular sense molecule array
11/15/2007WO2007130327A2 Influenza virus-like particle (vlp) compositions
11/15/2007WO2007128169A1 RECOMBINANT NEWCASTLE DISEASE LaSota LOW VIRULENT VACCINE STRAIN EXPRESSING AVIAN INFLUENZA VIRUS H5 SUBTYPE HA PROTEIN
11/15/2007WO2007128048A1 A hepatitis c vaccine delivery vehicle
11/15/2007US20070264646 Hbv Particles Containing Hbv-Rna
11/15/2007US20070264627 Retrovirus from the HIV group and its use
11/15/2007US20070264284 Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264281 Vaccination Vectors Derived From Lymphotropic Human Herpes Viruses 6 and 7
11/15/2007US20070264235 Polypeptide Having an Improved Cytosine Deaminase Activity
11/14/2007EP1854886A2 Cold-adapted equine influenza viruses
11/14/2007EP1853709A2 A method of truncating both ends of a large piece of dna
11/14/2007EP1080219B1 Amphotropic retrovirus packaging cell line, process for its production and use thereof
11/14/2007EP0866654B1 Method for treating hepatitis virus infection
11/14/2007CN101069744A 流感疫苗组合物 Influenza vaccine composition
11/13/2007US7294500 Genetic engineering hybrid protein
11/08/2007WO2007127264A2 Scalable production method for aav
11/08/2007WO2007125982A1 Novel cultured silkworm cell enabling highly efficient baculovirus production and protein production
11/08/2007WO2007125620A1 Method for isolating virus
11/08/2007WO2007125605A1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell
11/08/2007WO2007125146A1 Method for producing adenovirus vectors for gene therapy and dna sequences used therefor
11/08/2007WO2007124573A1 High-titer retroviral packaging cells
11/08/2007WO2007054297A3 Use of hydrophobic interaction chromatography for the attenuation of viruses
11/08/2007WO2007044428A3 Method for liberating bacteriophages and uses thereof
11/08/2007WO2006135379A3 Virus as a scaffold for hierarchical self-assembly of functional nanoscale devices
11/08/2007WO2004020971A3 Chromatographic methods for adenovirus purification
11/08/2007US20070261135 Disease resistance factors
11/08/2007US20070259429 Adenoviral vectors having a protein IX deletion
11/08/2007US20070259417 Directed evolution of novel binding proteins
11/08/2007US20070258999 Sars Virus Nucleotide and Amino Acid Sequences and Uses Thereof
11/08/2007US20070258997 Rescue of mumps virus from CDNA
11/08/2007CA2650676A1 Feline cell capable of being cultured without animal-derived protein, and method for producing virus and method for producing vaccine using thereof
11/08/2007CA2650270A1 High-titer retroviral packaging cells
11/08/2007CA2648086A1 Methods and compositions for inducing an immune response to hiv and models for testing
11/08/2007CA2647985A1 High titer recombinant influenza viruses for vaccines
11/07/2007EP1852511A1 Bovine immunodeficiency virus (biv) based vectors
11/07/2007EP1851246A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs
11/07/2007EP1087941B9 Thiolesters and uses thereof
11/07/2007EP0572401B2 Viral particles having altered host range
11/07/2007CN101068567A Chimeric phage-derived particles, methods for their production and use
11/07/2007CN100346827C Viral chimeras comprised of CAEV and HIV-1 genetic elements
11/07/2007CN100346826C Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
11/06/2007USRE39914 Isolating sample selected from the group consisting of a body fluid, feces, a sample of tissue and a sample of an organ from the person, obtaining an antibody specific to an adenovirus type 36p; assaying the sample using the antibody to test for the presence of the adenovirus type 36p
11/06/2007US7291723 Hepatitis G viral sequences for use as heterologous gene transfer tool; vaccine development; viricides
11/06/2007US7291453 Isolating DNA or corresponding mRNA from a mutated Hepatitis B Virus and screening for mutations in the HBV DNA polymerase
11/06/2007US7291342 Immunizing an avian with nonpathogenic immunogenically strain of Georgia 98 (GA-98) virus in attenuated or inactivated form; poultry vaccines
11/01/2007WO2007123961A2 Purification processes for isolating purified vesicular stomatitis virus from cell culture
11/01/2007WO2007122278A2 Novel spodoptera exigua nucleopolyhedrovirus genotypes and use thereof in controlling blights produced by this insect
11/01/2007WO2007059473A3 Methods for the production and purification of adenoviral vectors
11/01/2007WO2004032622A8 Production of peptides in plants as viral coat protein fusions
11/01/2007US20070254352 Methods for purifying adeno-associated virus particles
11/01/2007US20070254351 Vessicular composition comprising hepatitis C virus RNA sequences for use in designing drugs for treatment and prevention of viral infection
11/01/2007US20070253981 Canine influenza virus
11/01/2007US20070253979 Whole killed HIV virus devoid of outer envelope protein; incomplete Freund's Adjuvant; enhance beta chemokine levels, interferon gamma, cytotoxic T lymphocyte response; slows progression to AIDS; reduces viral burden; infant, child, pregnant; administer subcutaneously, intramuscularly, intramucosally
11/01/2007US20070253977 Recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients; engineered using reverse genetics with deletions of amino acids 151-221 and 178-219; for immunogenic compositions against RSV
11/01/2007US20070253972 For expressing foreign genetic information, e.g. foreign genes, for many applications, including immunogenic or pharmaceutical compositions for pathogens other than mumps, gene therapy, and cell targeting
11/01/2007US20070253936 Self-complementary parvoviral vectors, and methods for making and using the same
11/01/2007CA2648792A1 Purification processes for isolating purified vesicular stomatitis virus from cell culture
10/2007
10/31/2007EP1849873A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849799A1 Modified virus capsid protein and the use thereof
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007CN101065480A Animal protein-free media for cultivation of cells
10/31/2007CN101063151A Equine infectious anaemia virus (EIAV) based retroviral vectors
10/31/2007CN100345965C siRNA capable of inhibiting foot and mouth disease virus replication and infection and its preparation method
10/31/2007CN100345964C HIV-1 resistance strain and use thereof
10/30/2007US7288369 Incubating a cell containing an HCV RNA having a heterologous polynucleotide with a sequence encoding a transactivator; the cell has a transactivated coding region with an operator sequence linked to it that encodes a detectable marker; transactivator alters transcription of the coding region
10/30/2007CA2142007C Immunomodulatory peptides
10/26/2007CA2586302A1 H5 pseudotyped viruses and uses thereof
10/25/2007WO2007120193A2 Bionanomaterials and their synthesis
10/25/2007WO2007120120A2 Attenuated human parainfluenza virus, methods and uses thereof
10/25/2007WO2007118284A1 Influenza virus vaccine
10/25/2007WO2007046962A3 Cell lines harboring hepatitis virus and methods for using thereof
10/25/2007WO2006033999A3 Modified adenovirus containing a fiber replacement protein
10/25/2007US20070249629 Viral Polymerase Inhibitors
10/25/2007US20070249033 Methods of terminal sterilization of biological products
10/25/2007US20070249032 Flavivirus vaccine
10/25/2007US20070249015 Method of isolation and purification of trypsin from pronase protease and use thereof
10/25/2007US20070248942 bringing virus-containing blood into contact with a material for selectively removing viruses and leukocytes which comprises a water-insoluble carrier having a surface for adsorbing or removing viruses and leukocytes; useful when the blood contains hepatitis C virus
10/25/2007US20070248941 improves/extends period of viability of packed red blood cells and platelet concentrations; improves circulation half life upon transfusion
10/25/2007CA2649661A1 Influenza virus vaccine
10/25/2007CA2605878A1 Attenuated human parainfluenza virus, methods and uses thereof
10/24/2007EP1847605A2 Methods for producing members of specific binding pairs
10/24/2007EP1847596A1 Method of retrovirus storage
10/24/2007EP1846580A2 Methods for identifying compounds that inhibit hiv infection
10/24/2007EP1846041A2 Modified bacteriophage vectors and uses thereof
10/24/2007EP1846027A2 Improved vaccine against feline calicivirus
10/24/2007CN101060859A Refrigerator-temperature stable influenza vaccine compositions
10/24/2007CN101058803A Virus-like particles containing O-type foot-and-mouth disease virus IRES RNA, preparation method and application
10/24/2007CN101058800A Animal protein free media for cultivation of cells
10/23/2007US7285381 Insertion in amino acid sequence of structural protein; purification, mutagenesis, genetic engineering; higher titers; gene therapy, cell transformation
10/23/2007US7285280 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; therapy
10/23/2007US7285265 Stable adenoviral vectors and methods for propagation thereof
10/23/2007CA2206179C Vectors for tissue-specific replication
10/18/2007WO2007118249A2 Personal electronic device carrier
10/18/2007WO2007118134A2 A serum-free virus propagation platform for a virus vaccine candidate
10/18/2007WO2007116870A1 Method of preparing mature hepatocyte-like cell
10/18/2007WO2007087580A3 Y134.5 deficient hsv comprising a coding region of a member of the mapk pathway for the treatment of a cell proliferation disorder
1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 267